Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Email: |
sales@dcchemicals.com |
Products Intro: |
Product Name:Glucokinase activator 1 CAS:1328987-85-4 Purity:98% HPLC Package:100mg,250mg,1g
|
Glucokinase activator 1 manufacturers
|
| Glucokinase activator 1 Basic information |
Product Name: | Glucokinase activator 1 | Synonyms: | Glucokinase activator 1;Glucokise activator 1;Benzoic acid, 4-[[2-[[(2R)-2-[4-(cyclopropylsulfonyl)phenyl]-2-(2,4-difluorophenoxy)acetyl]amino]-5-thiazolyl]oxy]- | CAS: | 1328987-85-4 | MF: | C27H20F2N2O7S2 | MW: | 586.58 | EINECS: | | Product Categories: | | Mol File: | 1328987-85-4.mol |  |
| Glucokinase activator 1 Chemical Properties |
| Glucokinase activator 1 Usage And Synthesis |
Uses | Glucokinase activator 1 is a liver-directed glucokinase activator with an EC50 of 34 nM. | in vivo | Glucokinase activator 1 (3 to 300 mg/kg, oral, 180 minutes) shows a dose dependent improvement in glucose excursion in oGTT in a DIO mouse model of T2D. The predominant liver-directed tissue distribution of Glucokinase activator 1 ensures a good safety window with respect to hypoglycemia over a 10-fold dose range[1]. Animal Model: | Male C57BL/6J mice (age 8-10 weeks; 25±5 g)[1] | Dosage: | 1 or 3 mg/kg (i.v.), 30 mg/kg (oral) | Administration: | I.v. or oral | Result: | Showed an excellent PK profile and exhibited 35- and 68- fold higher liver concentrations at 1 and 3 h time point, respectively, compared with plasma[1]. |
Animal Model: | Male C57BL/6J mice of 10-12 weeks[1] | Dosage: | 3 to 300 mg/kg | Administration: | Oral (15, 30, 60, 120 and 180 minutes) | Result: | Demonstrated 21% and 34% significant AUC glucose reduction at oral dose of 30 and 100 mg/kg, respectively[1]. |
| References | [1] Deshpande AM, et al. Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia. Eur J Med Chem. 2017 Jun 16;133:268-286. DOI:10.1016/j.ejmech.2017.03.042 |
| Glucokinase activator 1 Preparation Products And Raw materials |
|